data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Nevro
(NYSE:NVRO)
$45.61
1.78[4.06%]
At close: Jul 1
$45.59
-0.0200[-0.04%]
After Hours: 4:31PM EDT
Day High/Low43.97 - 45.63
52 Week High/Low39.41 - 168.19
Open / Close44.09 / 45.59
Float / Outstanding30.5M / 35.3M
Vol / Avg.332.8K / 567.3K
Mkt Cap1.6B
P/E-
50d Avg. Price48.96
Div / Yield-
Payout Ratio-
EPS-0.98
Total Float30.5M

Nevro (NYSE:NVRO), Quotes and News Summary

Nevro (NYSE: NVRO)

Day High/Low43.97 - 45.63
52 Week High/Low39.41 - 168.19
Open / Close44.09 / 45.59
Float / Outstanding30.5M / 35.3M
Vol / Avg.332.8K / 567.3K
Mkt Cap1.6B
P/E-
50d Avg. Price48.96
Div / Yield-
Payout Ratio-
EPS-0.98
Total Float30.5M
Benzinga - Jun 7, 2022, 4:14PM
Benzinga - Jun 7, 2022, 9:14AM
Benzinga - May 26, 2022, 8:40AM
Benzinga - May 17, 2022, 8:52AM
Benzinga - May 5, 2022, 9:49AM
Benzinga - May 5, 2022, 6:37AM
Benzinga - May 4, 2022, 4:41PM
Benzinga - May 4, 2022, 4:40PM
Benzinga - May 4, 2022, 4:39PM
Benzinga - Apr 6, 2022, 5:14AM
Benzinga - Mar 7, 2022, 4:06PM
Benzinga - Feb 25, 2022, 9:37AM
Benzinga - Feb 24, 2022, 8:58AM
Benzinga - Feb 24, 2022, 7:21AM
Benzinga - Feb 24, 2022, 7:07AM
Benzinga - Feb 23, 2022, 4:29PM
Benzinga - Feb 23, 2022, 4:28PM
Benzinga - Feb 11, 2022, 8:30AM
Benzinga - Jan 25, 2022, 7:06AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-03
REV
Q1 2022Est.ActualSurprise
EPS-1.100-0.980 0.1200
REV86.180M87.842M1.662M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Nevro Questions & Answers

Q
How do I buy Nevro (NVRO) stock?
A

You can purchase shares of Nevro (NYSE: NVRO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Nevro's (NVRO) competitors?
Q
What is the target price for Nevro (NVRO) stock?
A

The latest price target for Nevro (NYSE: NVRO) was reported by Morgan Stanley on Tuesday, June 7, 2022. The analyst firm set a price target for 55.00 expecting NVRO to rise to within 12 months (a possible 20.59% upside). 28 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Nevro (NVRO)?
A

The stock price for Nevro (NYSE: NVRO) is $45.61 last updated July 1, 2022, 7:59 PM UTC.

Q
Does Nevro (NVRO) pay a dividend?
A

There are no upcoming dividends for Nevro.

Q
When is Nevro (NYSE:NVRO) reporting earnings?
A

Nevro’s Q2 earnings are confirmed for Wednesday, August 3, 2022.

Q
Is Nevro (NVRO) going to split?
A

There is no upcoming split for Nevro.

Q
What sector and industry does Nevro (NVRO) operate in?
A

Nevro is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.